Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin loading dose in diabetic foot patients
IRCT20240729062573N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2024
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vancomycin in diabetic foot infection (DFI), sponsored by Shahid Sadoughi University of Medical Sciences. Started Sep 2024; status: completed.
02
Drugs
vancomycin
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on IRCT20240729062573N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240729062573N1.